Skip to content

Insider · CIK 0001486189

Elisa Luqman V

officercfo

Files at NUTX (Nutex Health, Inc.), CDIO (Cardio Diagnostics Holdings, Inc.). First filing -, latest -.

In brief

Elisa Luqman V files SEC Form 4 as CFO at NUTX (Nutex Health, Inc.), and also at CDIO (Cardio Diagnostics Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Elisa Luqman V has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 7 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 10, 2026NUTX
Nutex Health, Inc.
MOption exercise
Common Stockindirect: See note (4)
+2,084$0.00$03,154Mar 11, 2026
Mar 10, 2026NUTX
Nutex Health, Inc.
FTax withholding
Common Stockindirect: See note (4)
-784$86.22$68k2,370Mar 11, 2026
Mar 10, 2026NUTX
Nutex Health, Inc.
MOption exercise
Restricted Stock Unitsderivative
+1,525$0.00$04,441Mar 11, 2026
Mar 1, 2025NUTX
Nutex Health, Inc.
MOption exercise
Common Stock
+1,250$0.00$01,336Apr 14, 2025
Apr 4, 2025NUTX
Nutex Health, Inc.
FTax withholding
Common Stock
-266$72.10$19k1,070Apr 14, 2025
Mar 10, 2025NUTX
Nutex Health, Inc.
MOption exercise
Restricted Stock Unitsderivative
+2,500$0.00$05,000Apr 14, 2025
Jan 23, 2024CDIO
Cardio Diagnostics Holdings, Inc.
AGrant or award
Stock Options (Right to Buy)derivative
+35,719$2.11$75k264,832Feb 21, 2024

Questions about Elisa Luqman V

Answered from the filings on this page, as of the latest one.

Is Elisa Luqman V buying or selling?

Elisa Luqman V has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Elisa Luqman V's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Elisa Luqman V has 0.

Where does Elisa Luqman V file Form 4?

Elisa Luqman V has filed Form 4 at NUTX (Nutex Health, Inc.) as Chief Legal Officer - SEC; CDIO (Cardio Diagnostics Holdings, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Elisa Luqman V: insider trades and track record | InsiderTell